| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.57 | 0.04 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.23 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |